Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

2.2K

Management of spasticity in children with cerebral palsy

Alireza Shamsoddini1, Susan Amirsalari2, Mohammad-Taghi Hollisaz1

  • 1Exercise Physiology Research Center.

Iranian Journal of Pediatrics
|March 11, 2015
PubMed

Insights

Cerebral palsy (CP) is a leading cause of childhood spasticity and disability. Early, multidisciplinary management of spasticity in children with CP is crucial, with various treatment options available.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Developmental Disabilities

Background:

  • Cerebral palsy (CP) is the primary cause of spasticity and physical impairment in children.
  • Spasticity is a frequent challenge in pediatric neurological conditions.
  • Effective management necessitates early and coordinated multidisciplinary intervention.

Purpose of the Study:

  • To review the diverse treatment modalities for managing spasticity in children with cerebral palsy.
  • To provide an overview of current clinical options for spasticity management.

Main Methods:

  • Literature review of available treatments for spasticity in pediatric cerebral palsy.
  • Synthesis of information on various therapeutic approaches.

Main Results:

  • Multiple treatment options exist for the clinical management of spasticity.
  • The article categorizes and describes these varied interventions.

Conclusions:

  • A comprehensive, multidisciplinary approach is essential for optimal spasticity management in children with CP.
  • Early intervention and a review of available treatment options are key to improving outcomes.

Keywords:
Cerebral PalsyIntrathecal BaclofenOccupational TherapyPhysical TherapyRhizotomySpasticity

More Related Videos

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

1.1K
Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models08:24

Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models

Published on: August 11, 2023

2.8K

Related Concept Videos

Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.4K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.6K